MOXIBUSTION	NNP
HAS	VBZ
A	DT
POSITIVE	JJ
EFFECT	NN
ON	IN
PULMONARY	NN
FIBROSIS	NN
:	:
AN	DT
ALTERNATIVE	NNP
APPROACH	NNP
.	.

BACKGROUND	NN
:	:
An	DT
increasing	VBG
number	NN
of	IN
people	NNS
suffered	VBD
idiopathic	JJ
fibrosis	NN
(	(
IPF	NN
)	)
and	CC
the	DT
current	JJ
treatment	NN
was	VBD
far	RB
from	IN
clinical	JJ
satisfaction	NN
.	.

Moxibustion	NNP
,	,
another	DT
effective	JJ
and	CC
safe	JJ
unconventional	JJ
therapy	NN
,	,
had	VBD
been	VBN
introduced	VBN
to	TO
treat	VB
this	DT
refractory	JJ
disease	NN
.	.

The	DT
study	NN
aimed	VBN
to	TO
investigate	VB
the	DT
effect	NN
of	IN
moxibustion	NN
on	IN
a	DT
bleomycin	NN
A5-induced	JJ
pulmonary	JJ
fibrosis	NN
model	NN
.	.

MATERIALS	NNS
AND	CC
METHODS	NNS
:	:
Sprague-dawley	NN
(	(
SD	NN
)	)
rats	NNS
were	VBD
randomly	RB
allocated	VBN
to	TO
the	DT
blank	JJ
group	NN
,	,
model	NN
group	NN
,	,
moxibustion	NN
group	NN
,	,
and	CC
prednisone	NN
group	NN
,	,
for	IN
which	WDT
they	PRP
received	VBD
no	DT
treatment	NN
,	,
modeling	NN
,	,
moxibustion	NN
treatment	NN
and	CC
prednisone	NN
treatment	NN
.	.

After	IN
four-week	JJ
treatment	NN
,	,
the	DT
rats	NNS
were	VBD
euthanized	VBN
for	IN
Hematoxylin	NNP
and	CC
Eosin	NNP
(	(
H.E.	NNP
)	)
staining	NN
,	,
and	CC
TGF-b1	NN
and	CC
IFN-y	NN
protein	NN
and	CC
mRNA	NN
detection	NN
in	IN
lungs	NNS
.	.

RESULTS	NNS
:	:
In	IN
the	DT
model	NN
group	NN
,	,
TGF-b1	NN
was	VBD
significantly	RB
increased	VBN
and	CC
IFN-y	NN
was	VBD
significantly	RB
decreased	VBN
at	IN
both	DT
protein	NN
and	CC
mRNA	NN
levels	NNS
in	IN
comparison	NN
to	TO
the	DT
blank	JJ
group	NN
.	.

In	IN
the	DT
moxibustion	NN
and	CC
prednisone	NN
group	NN
,	,
however	RB
,	,
TGF-b1	NN
was	VBD
decreased	VBN
and	CC
IFN-y	NN
was	VBD
increased	VBN
at	IN
both	DT
protein	NN
and	CC
mRNA	NN
levels	NNS
in	IN
comparison	NN
to	TO
the	DT
model	NN
groups	NNS
.	.

Compared	VBN
with	IN
prednisone	NN
,	,
moxibustion	NN
showed	VBD
comparable	JJ
effect	NN
in	IN
lowing	VBG
TGF-b1	NN
(	(
P	NN
>	JJR
0.05	CD
)	)
and	CC
better	JJR
effect	NN
in	IN
up-regulating	VBG
IFN-y	NN
(	(
P	NN
>	JJR
0.05	CD
)	)
.	.

CONCLUSION	NN
:	:
The	DT
study	NN
concludes	VBZ
moxibustion	NN
protected	VBD
pulmonary	JJ
fibrosis	NN
by	IN
downregulating	VBG
TGF-b1	NN
and	CC
upregulating	VBG
IFN-y	JJ
cytokines	NNS
at	IN
both	DT
mRNA	NN
and	CC
protein	NN
levels	NNS
,	,
and	CC
the	DT
effect	NN
was	VBD
comparable	JJ
to	TO
prednisone	NN
.	.

Moxibustion	NNP
could	MD
be	VB
used	VBN
as	IN
a	DT
therapeutic	JJ
alternative	NN
treatment	NN
for	IN
pulmonary	JJ
fibrosis	NN
.	.

